- Medtronic sales data based estimation. Over 100 publications on Medtronic CGMS® System GoldT are available, and more than 1500 leading hospitals throughout Europe use Medtronic subcutaneous sensor technology.
- Hoss U. et al: Accuracy of the Guardian continuous monitoring system under conditions of normal use. Abstract #1932, 64th annual meeting of the American diabetes association. 2004.
- Bode B., Gross K., Rikalo N., Schwartz S., Wahl T., Page C., Gross T., Mastrototaro J. Alarms Based on Real-Time Sensor Glucose Values Alert Patients to Hypo- and Hyperglycemia: The Guardian Continuous Monitoring System. Diabetes Technology & Therapeutics 2004;6:105-113.
- Jones TW, Davis EA. Hypoglycemia in children with type 1 diabetes: current issues and controversies. Pediatr Diabetes. 2003;4(3):143-50.
- Allen KV, Frier BM: Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr Pract. 2003 Nov-Dec;9(6):530-43.
- Lee S.W et al. Glucose excursions detected by the continuous glucose monitoring system and missed by routine self-monitoring blood glucose measurement in patients with type 1 and type 2 diabetes requiring insulin. Abstract #444, 64th annual meeting of the American diabetes association. 2004.
- Yogev Y;Ben-Haroush A;Chen R;Kaplan B;Phillip M;Hod M. Continuous glucose monitoring for treatment adjustment in diabetic pregnancies-a pilot study. Diabet Med 2003 Jul;20 (7): 558-562 PMID: 12823237
Download brochure
Click here to download a pdf brochure in English.
Register to receive more information
Register here to receive more information about Guardian® RT when the system becomes available.
For more information on Medtronic Minimed and diabetes products and therapies click here
|
